| NCT03826550 |
Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03826550 |
Completed |
Encube Ethicals Pvt. Ltd. |
2018-06-30 |
| NCT03325803 |
Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03325803 |
Completed |
Dong-A University |
2016-09-30 |
| NCT03322293 |
Daylight Photodynamic Therapy for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03322293 |
Completed |
University of California, San Francisco |
2018-12-01 |
| NCT03315286 |
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure |
https://ClinicalTrials.gov/show/NCT03315286 |
Completed |
Weill Medical College of Cornell University |
2019-01-31 |
| NCT03285490 |
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp (AK004) |
https://ClinicalTrials.gov/show/NCT03285490 |
Completed |
Athenex, Inc. |
2019-04-30 |
| NCT03285477 |
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp |
https://ClinicalTrials.gov/show/NCT03285477 |
Completed |
Athenex, Inc. |
2019-04-30 |
| NCT03246412 |
Nevus Doctor Clinical Decision Support for GPs |
https://ClinicalTrials.gov/show/NCT03246412 |
Recruiting |
University Hospital of North Norway |
2020-12-31 |
| NCT03243617 |
Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis Pilaris |
https://ClinicalTrials.gov/show/NCT03243617 |
Completed |
AOBiome LLC |
2016-06-08 |
| NCT03200912 |
An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03200912 |
Completed |
Actavis Inc. |
2017-03-07 |
| NCT03127670 |
Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion |
https://ClinicalTrials.gov/show/NCT03127670 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2017-12-31 |
| NCT03122457 |
Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide |
https://ClinicalTrials.gov/show/NCT03122457 |
Completed |
Icahn School of Medicine at Mount Sinai |
2018-07-19 |
| NCT03116698 |
A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period |
https://ClinicalTrials.gov/show/NCT03116698 |
Completed |
Dr. Reddy’s Laboratories Limited |
2017-11-13 |
| NCT03076892 |
Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS |
https://ClinicalTrials.gov/show/NCT03076892 |
Completed |
University Hospital, Lille |
2017-11-30 |
| NCT03066843 |
Photodynamic Therapy Incubation Times for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03066843 |
Active, not recruiting |
Northwestern University |
2021-12-31 |
| NCT03037541 |
Cryosurgery and Cream Combination for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03037541 |
Completed |
Wake Forest University Health Sciences |
2013-10-29 |
| NCT03006185 |
Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin |
https://ClinicalTrials.gov/show/NCT03006185 |
Completed |
Bispebjerg Hospital |
2016-11-30 |
| NCT02990221 |
Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs Cryotherapy |
https://ClinicalTrials.gov/show/NCT02990221 |
Completed |
University of Campania “Luigi Vanvitelli” |
2018-04-30 |
| NCT02976727 |
Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02976727 |
Completed |
Dong-A University |
2015-08-31 |
| NCT02952898 |
Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT02952898 |
Completed |
Gage Development Company, LLC |
2017-07-11 |
| NCT02938715 |
Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil |
https://ClinicalTrials.gov/show/NCT02938715 |
Completed |
University of California, Davis |
2017-09-30 |
| NCT02902822 |
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo |
https://ClinicalTrials.gov/show/NCT02902822 |
Completed |
Centro Studi Gised |
2019-05-31 |
| NCT02878382 |
Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT |
https://ClinicalTrials.gov/show/NCT02878382 |
Completed |
University of Sao Paulo |
2017-01-31 |
| NCT02866695 |
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients |
https://ClinicalTrials.gov/show/NCT02866695 |
Completed |
University of California, San Francisco |
2018-07-02 |
| NCT02844777 |
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02844777 |
Completed |
Vidac Pharma |
2017-05-31 |
| NCT02838628 |
A Phase 2a, Activity & Safety Study of KX2-391 Ointment in Subjects With Actinic Keratosis on the Face or Scalp |
https://ClinicalTrials.gov/show/NCT02838628 |
Completed |
Athenex, Inc. |
2016-12-31 |
| NCT02799082 |
Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis. |
https://ClinicalTrials.gov/show/NCT02799082 |
Completed |
Biofrontera Bioscience GmbH |
2008-10-31 |
| NCT02799069 |
Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT02799069 |
Completed |
Biofrontera Bioscience GmbH |
2009-08-31 |
| NCT02799030 |
A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02799030 |
Completed |
Biofrontera Bioscience GmbH |
2007-03-31 |
| NCT02759900 |
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders |
https://ClinicalTrials.gov/show/NCT02759900 |
Recruiting |
The Skin Center Dermatology Group |
2022-03-31 |
| NCT02716714 |
Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02716714 |
Completed |
Korea University |
2016-06-30 |
| NCT02670655 |
Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02670655 |
Completed |
Dong-A University |
2015-12-31 |
| NCT02667288 |
An Open-Label Safety Study of A-101 Solution |
https://ClinicalTrials.gov/show/NCT02667288 |
Completed |
Aclaris Therapeutics, Inc. |
2016-10-31 |
| NCT02667275 |
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis |
https://ClinicalTrials.gov/show/NCT02667275 |
Completed |
Aclaris Therapeutics, Inc. |
2016-10-31 |
| NCT02667236 |
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. |
https://ClinicalTrials.gov/show/NCT02667236 |
Completed |
Aclaris Therapeutics, Inc. |
2016-10-31 |
| NCT02654769 |
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02654769 |
Completed |
Actavis Inc. |
2015-09-30 |
| NCT02654717 |
Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp |
https://ClinicalTrials.gov/show/NCT02654717 |
Completed |
Promius Pharma, LLC |
2016-08-31 |
| NCT02650505 |
A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel |
https://ClinicalTrials.gov/show/NCT02650505 |
Completed |
LEO Pharma |
2016-06-30 |
| NCT02632110 |
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face |
https://ClinicalTrials.gov/show/NCT02632110 |
Completed |
DUSA Pharmaceuticals, Inc. |
2016-09-12 |
| NCT02628236 |
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2) |
https://ClinicalTrials.gov/show/NCT02628236 |
Completed |
DUSA Pharmaceuticals, Inc. |
2016-05-31 |
| NCT02622594 |
Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times |
https://ClinicalTrials.gov/show/NCT02622594 |
Completed |
Dermatology, Laser & Vein Specialists of the Carolinas |
2017-04-13 |
| NCT02616601 |
Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02616601 |
Completed |
Actavis Inc. |
2015-09-17 |
| NCT02611804 |
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp |
https://ClinicalTrials.gov/show/NCT02611804 |
Completed |
Teva Pharmaceuticals USA |
2016-08-31 |
| NCT02600598 |
Biological Effects of LEO 43204 in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02600598 |
Completed |
LEO Pharma |
2016-12-27 |
| NCT02594644 |
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT02594644 |
Completed |
University of California, Davis |
2016-06-22 |
| NCT02984072 |
Menthol for PDT Pain Relief |
https://ClinicalTrials.gov/show/NCT02984072 |
Completed |
University of Dundee |
2019-10-10 |
| NCT02559934 |
Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02559934 |
Completed |
G&E Herbal Biotechnology Co., LTD |
2019-01-31 |
| NCT02124733 |
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT02124733 |
Completed |
The Cleveland Clinic |
2016-10-31 |
| NCT02549352 |
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up |
https://ClinicalTrials.gov/show/NCT02549352 |
Completed |
LEO Pharma |
2016-09-22 |
| NCT02549339 |
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up |
https://ClinicalTrials.gov/show/NCT02549339 |
Completed |
LEO Pharma |
2016-08-05 |
| NCT03684772 |
Topical Ionic Contra-Viral Therapy in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03684772 |
Recruiting |
Maruho Co., Ltd. |
2019-09-30 |
| NCT02547363 |
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up |
https://ClinicalTrials.gov/show/NCT02547363 |
Completed |
LEO Pharma |
2016-08-17 |
| NCT02547233 |
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up |
https://ClinicalTrials.gov/show/NCT02547233 |
Completed |
LEO Pharma |
2016-11-30 |
| NCT02520700 |
A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT02520700 |
Completed |
St Vincent’s University Hospital, Ireland |
2015-05-31 |
| NCT02464709 |
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL) |
https://ClinicalTrials.gov/show/NCT02464709 |
Completed |
Joint Authority for Päijät-Häme Social and Health Care |
2017-10-31 |
| NCT02459795 |
To Compare Safety and Efficacy of Perrigo’s Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02459795 |
Completed |
Perrigo Company |
2015-12-31 |
| NCT02451579 |
A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT02451579 |
Completed |
Goldman, Butterwick, Fitzpatrick and Groff |
2016-12-31 |
| NCT02446223 |
Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015% |
https://ClinicalTrials.gov/show/NCT02446223 |
Completed |
Goldman, Butterwick, Fitzpatrick and Groff |
2016-09-30 |
| NCT02424305 |
Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions |
https://ClinicalTrials.gov/show/NCT02424305 |
Completed |
LEO Pharma |
2015-07-31 |
| NCT02411851 |
Treatment of Actinic Keratoses (AK) on the Face |
https://ClinicalTrials.gov/show/NCT02411851 |
Completed |
Icahn School of Medicine at Mount Sinai |
2016-06-30 |
| NCT02404389 |
Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients |
https://ClinicalTrials.gov/show/NCT02404389 |
Completed |
Novartis |
2016-01-27 |
| NCT02385318 |
To Compare Safety and Efficacy of Perrigo’s Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02385318 |
Completed |
Perrigo Company |
2015-12-31 |
| NCT02373371 |
Actinic Keratoses Treatment With Metvix® in Combination With Light |
https://ClinicalTrials.gov/show/NCT02373371 |
Completed |
University Hospital, Limoges |
2016-11-22 |
| NCT02361216 |
Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest |
https://ClinicalTrials.gov/show/NCT02361216 |
Completed |
LEO Pharma |
2016-03-31 |
| NCT02354391 |
Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02354391 |
Active, not recruiting |
Pacific Dermaesthetics |
2019-12-31 |
| NCT02352987 |
Effect of Neem Extract, Propylene Glycol and Salicylic Acid Combination in the Treatment of Arsenical Palmar Keratosis |
https://ClinicalTrials.gov/show/NCT02352987 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2015-09-30 |
| NCT02337205 |
Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02337205 |
Completed |
Athenex, Inc. |
2016-03-31 |
| NCT02325661 |
Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL) |
https://ClinicalTrials.gov/show/NCT02325661 |
Completed |
University of Zurich |
2014-12-31 |
| NCT02305888 |
Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively |
https://ClinicalTrials.gov/show/NCT02305888 |
Completed |
LEO Pharma |
2015-07-31 |
| NCT02289768 |
Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT02289768 |
Completed |
Almirall, S.A. |
2015-09-30 |
| NCT02281136 |
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick |
https://ClinicalTrials.gov/show/NCT02281136 |
Completed |
DUSA Pharmaceuticals, Inc. |
2015-04-30 |
| NCT02278861 |
Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02278861 |
Completed |
Universidade Federal de Goias |
2014-04-30 |
| NCT02260180 |
Study of A-101 for the Treatment of Seborrheic Keratosis |
https://ClinicalTrials.gov/show/NCT02260180 |
Completed |
Aclaris Therapeutics, Inc. |
2015-03-31 |
| NCT02251652 |
Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT02251652 |
Completed |
Icahn School of Medicine at Mount Sinai |
2014-12-31 |
| NCT02248298 |
Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02248298 |
Completed |
Dong-A University |
2014-06-30 |
| NCT02242747 |
Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02242747 |
Completed |
University of Sao Paulo |
2014-07-31 |
| NCT02239679 |
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT02239679 |
Completed |
DUSA Pharmaceuticals, Inc. |
2016-07-31 |
| NCT02160626 |
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis |
https://ClinicalTrials.gov/show/NCT02160626 |
Completed |
Aclaris Therapeutics, Inc. |
2014-12-31 |
| NCT02149342 |
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL |
https://ClinicalTrials.gov/show/NCT02149342 |
Completed |
Joint Authority for Päijät-Häme Social and Health Care |
2015-09-30 |
| NCT02137785 |
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities |
https://ClinicalTrials.gov/show/NCT02137785 |
Completed |
DUSA Pharmaceuticals, Inc. |
2015-03-31 |
| NCT02126670 |
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02126670 |
Completed |
Promius Pharma, LLC |
2014-09-30 |
| NCT02124239 |
Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions |
https://ClinicalTrials.gov/show/NCT02124239 |
Completed |
LEO Pharma |
2014-11-30 |
| NCT02120898 |
A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT02120898 |
Completed |
Actavis Inc. |
2014-04-30 |
| NCT02120456 |
Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02120456 |
Completed |
LEO Pharma |
2015-05-31 |
| NCT02085395 |
Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02085395 |
Completed |
G&E Herbal Biotechnology Co., LTD |
2010-04-30 |
| NCT02062853 |
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video |
https://ClinicalTrials.gov/show/NCT02062853 |
Completed |
University of California, Davis |
2016-06-30 |
| NCT01302925 |
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects |
https://ClinicalTrials.gov/show/NCT01302925 |
Completed |
Peplin |
2011-03-31 |
| NCT01281644 |
Treatment of Keratosis Pilaris With 810 nm Diode Laser |
https://ClinicalTrials.gov/show/NCT01281644 |
Completed |
Northwestern University |
2011-10-31 |
| NCT02029066 |
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02029066 |
Completed |
G&E Herbal Biotechnology Co., LTD |
2014-02-28 |
| NCT02019355 |
Actinic Keratosis Study |
https://ClinicalTrials.gov/show/NCT02019355 |
Completed |
Washington University School of Medicine |
2015-03-31 |
| NCT01998984 |
Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01998984 |
Completed |
LEO Pharma |
2014-07-31 |
| NCT01986920 |
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis |
https://ClinicalTrials.gov/show/NCT01986920 |
Completed |
Aclaris Therapeutics, Inc. |
2014-02-25 |
| NCT01966120 |
Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT) |
https://ClinicalTrials.gov/show/NCT01966120 |
Completed |
Biofrontera Bioscience GmbH |
2014-09-30 |
| NCT01962987 |
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01962987 |
Completed |
Actavis Inc. |
2013-09-30 |
| NCT01935531 |
Effects of Topical Diclofenac on Tumor Metabolism |
https://ClinicalTrials.gov/show/NCT01935531 |
Completed |
University Hospital Regensburg |
2016-01-31 |
| NCT01922050 |
A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01922050 |
Completed |
LEO Pharma |
2014-11-30 |
| NCT01921907 |
Evaluation of a Topical Treatment for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01921907 |
Completed |
Assuta Hospital Systems |
2014-06-30 |
| NCT01905891 |
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients |
https://ClinicalTrials.gov/show/NCT01905891 |
Completed |
Northwestern University |
2014-11-30 |
| NCT01898936 |
Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT01898936 |
Completed |
Oslo University Hospital |
2016-09-30 |
| NCT04319159 |
Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK) |
https://ClinicalTrials.gov/show/NCT04319159 |
Recruiting |
Biofrontera Bioscience GmbH |
2020-09-30 |
| NCT01892137 |
Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% |
https://ClinicalTrials.gov/show/NCT01892137 |
Completed |
LEO Pharma |
2014-03-31 |
| NCT01836367 |
Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp |
https://ClinicalTrials.gov/show/NCT01836367 |
Completed |
Icahn School of Medicine at Mount Sinai |
2013-08-31 |
| NCT01821391 |
Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT01821391 |
Completed |
Galderma |
2014-01-31 |
| NCT01820260 |
Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01820260 |
Completed |
LEO Pharma |
2014-08-31 |
| NCT01812837 |
The Use of Microneedles in Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT01812837 |
Completed |
University of California, Davis |
2014-03-31 |
| NCT01803477 |
Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm |
https://ClinicalTrials.gov/show/NCT01803477 |
Completed |
LEO Pharma |
2013-10-31 |
| NCT01787383 |
A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities |
https://ClinicalTrials.gov/show/NCT01787383 |
Completed |
LEO Pharma |
2014-01-31 |
| NCT01757613 |
Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01757613 |
Completed |
Dolorgiet GmbH & Co. KG |
2014-01-31 |
| NCT01752972 |
Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic |
https://ClinicalTrials.gov/show/NCT01752972 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2011-12-31 |
| NCT01748669 |
Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis |
https://ClinicalTrials.gov/show/NCT01748669 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2012-07-31 |
| NCT01742663 |
A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01742663 |
Completed |
Taro Pharmaceuticals USA |
2013-07-31 |
| NCT01735097 |
Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis |
https://ClinicalTrials.gov/show/NCT01735097 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2013-11-30 |
| NCT01731756 |
Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis |
https://ClinicalTrials.gov/show/NCT01731756 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2013-12-31 |
| NCT01703078 |
Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01703078 |
Completed |
LEO Pharma |
2013-03-31 |
| NCT01686152 |
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01686152 |
Completed |
Teva Pharmaceuticals USA |
2013-08-31 |
| NCT01600014 |
Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp |
https://ClinicalTrials.gov/show/NCT01600014 |
Completed |
LEO Pharma |
2014-02-28 |
| NCT01583816 |
Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions |
https://ClinicalTrials.gov/show/NCT01583816 |
Completed |
Spirig Pharma Ltd. |
2013-11-30 |
| NCT03327831 |
Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT03327831 |
Completed |
University of California, Irvine |
2017-02-28 |
| NCT01541553 |
A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp |
https://ClinicalTrials.gov/show/NCT01541553 |
Completed |
LEO Pharma |
2013-07-31 |
| NCT01516515 |
Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01516515 |
Completed |
G&E Herbal Biotechnology Co., LTD |
2017-12-31 |
| NCT01502020 |
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclaraâ„¢ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT01502020 |
Completed |
Actavis Mid-Atlantic LLC |
2011-08-31 |
| NCT01493921 |
Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment |
https://ClinicalTrials.gov/show/NCT01493921 |
Completed |
G&E Herbal Biotechnology Co., LTD |
2015-11-30 |
| NCT01475955 |
Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK) |
https://ClinicalTrials.gov/show/NCT01475955 |
Completed |
DUSA Pharmaceuticals, Inc. |
2012-11-30 |
| NCT01475071 |
Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT01475071 |
Completed |
Galderma |
2012-11-30 |
| NCT01459393 |
Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment |
https://ClinicalTrials.gov/show/NCT01459393 |
Completed |
Barretos Cancer Hospital |
2011-11-30 |
| NCT01458587 |
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) |
https://ClinicalTrials.gov/show/NCT01458587 |
Completed |
DUSA Pharmaceuticals, Inc. |
2012-07-31 |
| NCT01453179 |
Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) |
https://ClinicalTrials.gov/show/NCT01453179 |
Completed |
MEDA Pharma GmbH & Co. KG |
2015-03-31 |
| NCT01449513 |
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy |
https://ClinicalTrials.gov/show/NCT01449513 |
Completed |
LEO Pharma |
2012-05-31 |
| NCT01444989 |
Development and Validation of a Quality of Life Instrument for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01444989 |
Completed |
Wake Forest University Health Sciences |
2011-12-31 |
| NCT01442727 |
Selenium in the Treatment of Arsenic Toxicity and Cancers |
https://ClinicalTrials.gov/show/NCT01442727 |
Completed |
Texas Tech University |
2009-04-30 |
| NCT01387711 |
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology |
https://ClinicalTrials.gov/show/NCT01387711 |
Completed |
LEO Pharma |
2012-06-30 |
| NCT01358851 |
LAS41005 in Hyperkeratotic Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01358851 |
Completed |
Almirall, S.A. |
2012-03-31 |
| NCT01354717 |
Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo |
https://ClinicalTrials.gov/show/NCT01354717 |
Completed |
Spear Pharmaceuticals |
2011-03-31 |
| NCT04336514 |
A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar Pressures |
https://ClinicalTrials.gov/show/NCT04336514 |
Active, not recruiting |
University Health Network, Toronto |
2021-05-31 |
| NCT04269395 |
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study |
https://ClinicalTrials.gov/show/NCT04269395 |
Recruiting |
Galderma R&D |
2020-06-30 |
| NCT04249115 |
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study |
https://ClinicalTrials.gov/show/NCT04249115 |
Active, not recruiting |
Pulse Biosciences, Inc. |
2020-02-29 |
| NCT04229277 |
Fast Track Diagnosis of Skin Cancer by Advanced Imaging |
https://ClinicalTrials.gov/show/NCT04229277 |
Active, not recruiting |
University Hospital Bispebjerg and Frederiksberg |
2020-03-22 |
| NCT04085367 |
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face |
https://ClinicalTrials.gov/show/NCT04085367 |
Recruiting |
Galderma R&D |
2020-10-06 |
| NCT03963102 |
Duration of Ameluz Application in Acral Actinic Keratoses Response |
https://ClinicalTrials.gov/show/NCT03963102 |
Recruiting |
Royal Cornwall Hospitals Trust |
2020-10-01 |
| NCT03914417 |
Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream |
https://ClinicalTrials.gov/show/NCT03914417 |
Completed |
Icahn School of Medicine at Mount Sinai |
2016-06-30 |
| NCT03906253 |
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia |
https://ClinicalTrials.gov/show/NCT03906253 |
Recruiting |
Wright State Physicians |
2025-12-31 |
| NCT03846531 |
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study |
https://ClinicalTrials.gov/show/NCT03846531 |
Completed |
Pulse Biosciences, Inc. |
2017-11-13 |
| NCT03805737 |
Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03805737 |
Recruiting |
Dartmouth-Hitchcock Medical Center |
2020-11-30 |
| NCT03731988 |
Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03731988 |
Completed |
Dong-A University |
2017-10-30 |
| NCT03727074 |
Bioequivalence Study to Compare Sol-Gel Technologies’ 5-FU Cream With Efudex® (5-FU) Cream |
https://ClinicalTrials.gov/show/NCT03727074 |
Completed |
Sol-Gel Technologies, Ltd. |
2019-12-19 |
| NCT03697590 |
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage |
https://ClinicalTrials.gov/show/NCT03697590 |
Completed |
Bispebjerg Hospital |
2017-12-20 |
| NCT03643744 |
Photodynamic Therapy-Induced Immune Modulation: Part III |
https://ClinicalTrials.gov/show/NCT03643744 |
Recruiting |
Wright State Physicians |
2021-03-31 |
| NCT03642535 |
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention |
https://ClinicalTrials.gov/show/NCT03642535 |
Recruiting |
Shanghai Dermatology Hospital |
2025-06-01 |
| NCT03635853 |
Identification of Compound Isolated From Cock’s Comb and Its Effect on Arsenical Palmar Keratosis |
https://ClinicalTrials.gov/show/NCT03635853 |
Recruiting |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2018-12-31 |
| NCT03632733 |
Effects of Antimicrobials on the Altered Skin Flora in Arsenical Keratosis |
https://ClinicalTrials.gov/show/NCT03632733 |
Recruiting |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2018-10-30 |
| NCT03606122 |
5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities |
https://ClinicalTrials.gov/show/NCT03606122 |
Completed |
photonamic GmbH & Co. KG |
2019-07-16 |
| NCT03596619 |
The Study of Plum-blossom Needling Enhancing Efficacy of Aminolevulinic Acid-photodynamic Therapy for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03596619 |
Recruiting |
Shanghai Dermatology Hospital |
2021-12-30 |
| NCT03575780 |
Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03575780 |
Completed |
Athenex, Inc. |
2019-04-25 |
| NCT03511326 |
PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK |
https://ClinicalTrials.gov/show/NCT03511326 |
Completed |
Galderma |
2017-11-28 |
| NCT03508856 |
Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin |
https://ClinicalTrials.gov/show/NCT03508856 |
Completed |
Skin Laser & Surgery Specialists |
2016-08-09 |
| NCT03487588 |
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses |
https://ClinicalTrials.gov/show/NCT03487588 |
Completed |
Aclaris Therapeutics, Inc. |
2018-11-14 |
| NCT03483935 |
Microwave Therapy for Treatment of Precancerous Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT03483935 |
Completed |
University of Dundee |
2019-02-28 |
| NCT03447925 |
Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients |
https://ClinicalTrials.gov/show/NCT03447925 |
Recruiting |
Universidade do Vale do Sapucai |
2019-10-01 |
| NCT01265602 |
Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT01265602 |
Completed |
Almirall, S.A. |
2012-03-31 |
| NCT01260987 |
Fractional CO2 Laser Assisted Photodynamic Therapy |
https://ClinicalTrials.gov/show/NCT01260987 |
Completed |
Bispebjerg Hospital |
2012-08-31 |
| NCT01214564 |
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis |
https://ClinicalTrials.gov/show/NCT01214564 |
Completed |
Peplin |
2010-12-31 |
| NCT01159860 |
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses? |
https://ClinicalTrials.gov/show/NCT01159860 |
Completed |
Milton S. Hershey Medical Center |
2012-05-11 |
| NCT01053000 |
Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT01053000 |
Completed |
Stewart, Roger H., M.D., P.A. |
2010-11-30 |
| NCT01000636 |
Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT) |
https://ClinicalTrials.gov/show/NCT01000636 |
Completed |
Galderma |
2011-10-31 |
| NCT00991861 |
Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00991861 |
Completed |
Almirall, S.A. |
2010-02-28 |
| NCT00987246 |
Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00987246 |
Completed |
Almirall, S.A. |
2009-06-30 |
| NCT00948428 |
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldaraâ„¢ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00948428 |
Completed |
Actavis Inc. |
2009-03-31 |
| NCT00942604 |
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations |
https://ClinicalTrials.gov/show/NCT00942604 |
Completed |
Peplin |
2009-10-31 |
| NCT00926952 |
Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion |
https://ClinicalTrials.gov/show/NCT00926952 |
Completed |
Innovaderm Research Inc. |
2010-12-31 |
| NCT00917306 |
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) |
https://ClinicalTrials.gov/show/NCT00917306 |
Completed |
Peplin |
2009-09-30 |
| NCT00916006 |
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) |
https://ClinicalTrials.gov/show/NCT00916006 |
Completed |
Peplin |
2009-09-30 |
| NCT00915551 |
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) |
https://ClinicalTrials.gov/show/NCT00915551 |
Completed |
Peplin |
2009-09-30 |
| NCT00894647 |
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery |
https://ClinicalTrials.gov/show/NCT00894647 |
Completed |
Graceway Pharmaceuticals, LLC |
2010-02-28 |
| NCT00859105 |
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00859105 |
Completed |
Apotex Inc. |
2008-11-30 |
| NCT00852137 |
A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00852137 |
Completed |
Peplin |
2009-06-30 |
| NCT00850811 |
A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00850811 |
Completed |
Peplin |
2009-04-30 |
| NCT00850681 |
A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00850681 |
Completed |
Peplin |
2009-04-30 |
| NCT00843323 |
Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin |
https://ClinicalTrials.gov/show/NCT00843323 |
Completed |
University of Sao Paulo |
2009-03-31 |
| NCT03083470 |
Study of SOR007 Ointment for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03083470 |
Completed |
DFB Soria, LLC |
2018-03-12 |
| NCT00828568 |
Bioequivalence Study of Two Imiquimod Cream 5% |
https://ClinicalTrials.gov/show/NCT00828568 |
Completed |
Taro Pharmaceuticals USA |
2009-03-31 |
| NCT03279328 |
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents |
https://ClinicalTrials.gov/show/NCT03279328 |
Completed |
University of Arizona |
2018-07-31 |
| NCT01788007 |
Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis. |
https://ClinicalTrials.gov/show/NCT01788007 |
Completed |
Taro Pharmaceuticals USA |
2013-10-31 |
| NCT01611480 |
Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head |
https://ClinicalTrials.gov/show/NCT01611480 |
Completed |
Moberg Pharma AB |
2013-01-31 |
| NCT01926496 |
Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% |
https://ClinicalTrials.gov/show/NCT01926496 |
Completed |
LEO Pharma |
2019-07-11 |
| NCT01893203 |
Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL) |
https://ClinicalTrials.gov/show/NCT01893203 |
Completed |
Joint Authority for Päijät-Häme Social and Health Care |
2014-12-31 |
| NCT01541228 |
Photodynamic Treatment of Actinic Keratoses With Different Light Doses |
https://ClinicalTrials.gov/show/NCT01541228 |
Completed |
Lithuanian University of Health Sciences |
2011-04-30 |
| NCT04140292 |
Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT04140292 |
Recruiting |
Case Comprehensive Cancer Center |
2021-12-31 |
| NCT04396184 |
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT04396184 |
Recruiting |
Shanghai Dermatology Hospital |
2021-04-30 |
| NCT03148691 |
A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis |
https://ClinicalTrials.gov/show/NCT03148691 |
Completed |
Aclaris Therapeutics, Inc. |
2018-02-28 |
| NCT02644187 |
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol |
https://ClinicalTrials.gov/show/NCT02644187 |
Completed |
Vastra Gotaland Region |
2017-03-31 |
| NCT02406014 |
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp |
https://ClinicalTrials.gov/show/NCT02406014 |
Completed |
LEO Pharma |
2016-06-30 |
| NCT02100813 |
Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT02100813 |
Completed |
LEO Pharma |
2015-03-31 |
| NCT03210740 |
Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT03210740 |
Completed |
AmDerma |
2018-02-13 |
| NCT00786994 |
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00786994 |
Completed |
Amryt Pharma |
2010-11-30 |
| NCT00777127 |
Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00777127 |
Completed |
MEDA Pharma GmbH & Co. KG |
2012-11-30 |
| NCT00774787 |
Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00774787 |
Completed |
Rigel Dermatology |
2010-03-31 |
| NCT00742391 |
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations |
https://ClinicalTrials.gov/show/NCT00742391 |
Completed |
Peplin |
2009-02-28 |
| NCT00711178 |
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT) |
https://ClinicalTrials.gov/show/NCT00711178 |
Completed |
Bispebjerg Hospital |
2009-01-31 |
| NCT00710203 |
Dermatosis Papulosa Nigra |
https://ClinicalTrials.gov/show/NCT00710203 |
Completed |
University of California, Davis |
2009-12-31 |
| NCT00700063 |
A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) |
https://ClinicalTrials.gov/show/NCT00700063 |
Completed |
Peplin |
2008-10-31 |
| NCT00696488 |
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population |
https://ClinicalTrials.gov/show/NCT00696488 |
Completed |
Wake Forest University Health Sciences |
2007-08-31 |
| NCT00695578 |
Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy |
https://ClinicalTrials.gov/show/NCT00695578 |
Completed |
Wake Forest University Health Sciences |
2007-06-30 |
| NCT00659893 |
Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 |
https://ClinicalTrials.gov/show/NCT00659893 |
Completed |
Peplin |
2008-11-30 |
| NCT00605176 |
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) |
https://ClinicalTrials.gov/show/NCT00605176 |
Completed |
Graceway Pharmaceuticals, LLC |
2008-07-31 |
| NCT00603798 |
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) |
https://ClinicalTrials.gov/show/NCT00603798 |
Completed |
Graceway Pharmaceuticals, LLC |
2008-07-31 |
| NCT00558688 |
A Photodynamic Therapy for Treatment of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00558688 |
Completed |
Northwestern University |
2009-08-31 |
| NCT00544297 |
A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand |
https://ClinicalTrials.gov/show/NCT00544297 |
Completed |
Peplin |
2008-01-31 |
| NCT00544258 |
Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 |
https://ClinicalTrials.gov/show/NCT00544258 |
Completed |
Peplin |
2008-05-31 |
| NCT00472459 |
PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin Cancer |
https://ClinicalTrials.gov/show/NCT00472459 |
Completed |
Galderma |
NA |
| NCT00432224 |
Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light |
https://ClinicalTrials.gov/show/NCT00432224 |
Completed |
Bispebjerg Hospital |
NA |
| NCT00427050 |
A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel |
https://ClinicalTrials.gov/show/NCT00427050 |
Completed |
Peplin |
2007-11-30 |
| NCT00377273 |
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00377273 |
Completed |
Sanofi |
NA |
| NCT00375739 |
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00375739 |
Completed |
Peplin |
2007-06-30 |
| NCT00335179 |
Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream |
https://ClinicalTrials.gov/show/NCT00335179 |
Completed |
Graceway Pharmaceuticals, LLC |
2003-07-31 |
| NCT00308867 |
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK |
https://ClinicalTrials.gov/show/NCT00308867 |
Completed |
photonamic GmbH & Co. KG |
2007-06-30 |
| NCT00308854 |
Photodynamic Therapy With PD P 506 A Compared With Placebo-PDT for the Treatment of AK |
https://ClinicalTrials.gov/show/NCT00308854 |
Completed |
photonamic GmbH & Co. KG |
2007-08-31 |
| NCT00306800 |
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp |
https://ClinicalTrials.gov/show/NCT00306800 |
Completed |
Galderma |
NA |
| NCT00304239 |
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp |
https://ClinicalTrials.gov/show/NCT00304239 |
Completed |
Galderma |
NA |
| NCT00294320 |
Evaluation of Two Different Non-Invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions |
https://ClinicalTrials.gov/show/NCT00294320 |
Completed |
MEDA Pharma GmbH & Co. KG |
2007-01-31 |
| NCT00269074 |
Effect of IDEA-070 on Pain and Inflammation Induced by PDT |
https://ClinicalTrials.gov/show/NCT00269074 |
Completed |
IDEA AG |
NA |
| NCT00239135 |
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel |
https://ClinicalTrials.gov/show/NCT00239135 |
Completed |
Peplin |
2005-12-31 |
| NCT00204542 |
Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head |
https://ClinicalTrials.gov/show/NCT00204542 |
Completed |
University Hospital Tuebingen |
2009-03-31 |
| NCT00189267 |
A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients |
https://ClinicalTrials.gov/show/NCT00189267 |
Completed |
MEDA Pharma GmbH & Co. KG |
NA |
| NCT00175643 |
Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00175643 |
Completed |
University of British Columbia |
NA |
| NCT00121511 |
The Effect of Efudex Treatment on Photoaged Skin |
https://ClinicalTrials.gov/show/NCT00121511 |
Completed |
University of Michigan |
NA |
| NCT00116649 |
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00116649 |
Completed |
Graceway Pharmaceuticals, LLC |
2007-05-31 |
| NCT00115154 |
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands |
https://ClinicalTrials.gov/show/NCT00115154 |
Completed |
Graceway Pharmaceuticals, LLC |
NA |
| NCT00110682 |
Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00110682 |
Completed |
Derm Research @ 888 Inc. |
2006-10-31 |
| NCT00107965 |
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses |
https://ClinicalTrials.gov/show/NCT00107965 |
Completed |
Peplin |
2005-09-30 |
| NCT00089180 |
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant |
https://ClinicalTrials.gov/show/NCT00089180 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00021294 |
Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis |
https://ClinicalTrials.gov/show/NCT00021294 |
Completed |
University of Arizona |
2002-06-30 |